Genetically encoded dihydroxyphenylalanine coupled with tyrosinase for strain promoted labeling.


Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
15 11 2021
Historique:
received: 21 06 2021
revised: 25 09 2021
accepted: 05 10 2021
pubmed: 11 11 2021
medline: 14 1 2022
entrez: 10 11 2021
Statut: ppublish

Résumé

Protein modifications through genetic code engineering have a remarkable impact on macromolecule engineering, protein translocation, protein-protein interaction, and cell biology. We used the newly developed molecular biology approach, genetic code engineering, for fine-tuning of proteins for biological availability. Here, we have introduced 3, 4-dihydroxy-l-phenylalanine in recombinant proteins by selective pressure incorporation method for protein-based cell labeling applications. The congener proteins treated with tyrosinase convert 3, 4-dihydroxy-l-phenylalanine to dopaquinone for strain-promoted click chemistry. Initially, the single-step Strain-Promoted Oxidation-Controlled Cyclooctyne-1,2-quinone Cycloaddition was studied using tyrosinase catalyzed congener protein and optimized the temporally controlled conjugation with (1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethanol. Then, the feasibility of tyrosinase-treated congener annexin A5 with easily reactive quinone functional moiety was conjugated with fluorescent tag dibenzocyclooctyne-PEG4-TAMRA for labeling of apoptotic cells. Thus, the congener proteins-based products demonstrate selective cell labeling and apoptosis detection in EA.hy926 cells even after the protein modifications. Hence, genetic code engineering can be coupled with click chemistry to develop various protein-based fluorescent labels.

Identifiants

pubmed: 34757293
pii: S0968-0896(21)00468-5
doi: 10.1016/j.bmc.2021.116460
pii:
doi:

Substances chimiques

Benzoquinones 0
Recombinant Proteins 0
Dihydroxyphenylalanine 63-84-3
dopaquinone 8F09Y50AX6
Monophenol Monooxygenase EC 1.14.18.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

116460

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Augustine George (A)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India.

Mohan Indhu (M)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Sundarapandian Ashokraj (S)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Ganesh Shanmugam (G)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India; Division of Organic and Bio-Organic Chemistry, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India.

Ponesakki Ganesan (P)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India.

Numbi Ramudu Kamini (NR)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India.

Niraikulam Ayyadurai (N)

Department of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR) - Central Leather Research Institute (CLRI), Chennai, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic address: ayyadurai@clri.res.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH